Transgene SA (EPA: TNG)
France
· Delayed Price · Currency is EUR 0.788
+0.006 (0.77%)
Nov 22, 2024, 5:35 PM CET
Transgene Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 1.18 | 1.18 | 3.13 | 9.99 | 2.98 | 6.65 | Upgrade
|
| Other Revenue | 5.31 | 6.72 | 7.22 | 7.25 | 6.59 | 6.64 | Upgrade
|
| Revenue | 6.49 | 7.9 | 10.34 | 17.24 | 9.57 | 13.3 | Upgrade
|
| Revenue Growth (YoY) | -28.00% | -23.63% | -40.00% | 80.08% | -28.00% | 87.69% | Upgrade
|
| Cost of Revenue | 29.44 | 29.59 | 32.17 | 32.88 | 27.35 | 31.39 | Upgrade
|
| Gross Profit | -22.95 | -21.69 | -21.82 | -15.64 | -17.77 | -18.09 | Upgrade
|
| Selling, General & Admin | 8.29 | 6.99 | 7.91 | 7.37 | 6.55 | 7.13 | Upgrade
|
| Other Operating Expenses | -0.07 | 1.34 | 0.16 | 0.68 | 0.02 | 0.17 | Upgrade
|
| Operating Expenses | 8.23 | 8.32 | 8.07 | 8.05 | 6.56 | 7.31 | Upgrade
|
| Operating Income | -31.17 | -30.01 | -29.9 | -23.7 | -24.34 | -25.4 | Upgrade
|
| Interest Expense | -0.67 | -0.17 | -0.8 | -0.46 | -1.96 | -1.44 | Upgrade
|
| Interest & Investment Income | 8.73 | 8.67 | 2.48 | 0.8 | 0.09 | 0.13 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.26 | -0.19 | 0.11 | 0.17 | -0.01 | -0.2 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.02 | -0.59 | -19.03 | -0.13 | -0.1 | 8.16 | Upgrade
|
| EBT Excluding Unusual Items | -22.88 | -22.29 | -47.14 | -23.32 | -26.31 | -18.75 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 14.35 | 3.79 | 9.08 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.04 | -0.04 | -0.01 | -0 | - | -0.06 | Upgrade
|
| Pretax Income | -22.91 | -22.33 | -32.8 | -19.54 | -17.23 | -18.8 | Upgrade
|
| Earnings From Continuing Operations | -22.91 | -22.33 | -32.8 | -19.54 | -17.23 | -18.8 | Upgrade
|
| Net Income | -22.91 | -22.33 | -32.8 | -19.54 | -17.23 | -18.8 | Upgrade
|
| Net Income to Common | -22.91 | -22.33 | -32.8 | -19.54 | -17.23 | -18.8 | Upgrade
|
| Shares Outstanding (Basic) | 101 | 101 | 100 | 91 | 82 | 82 | Upgrade
|
| Shares Outstanding (Diluted) | 101 | 101 | 100 | 91 | 82 | 82 | Upgrade
|
| Shares Change (YoY) | 1.17% | 1.09% | 9.21% | 11.04% | 0.36% | 32.37% | Upgrade
|
| EPS (Basic) | -0.23 | -0.22 | -0.33 | -0.21 | -0.21 | -0.23 | Upgrade
|
| EPS (Diluted) | -0.23 | -0.22 | -0.33 | -0.21 | -0.21 | -0.23 | Upgrade
|
| Free Cash Flow | -38.81 | -37.34 | -21.8 | -26.58 | -29.55 | -24.1 | Upgrade
|
| Free Cash Flow Per Share | -0.38 | -0.37 | -0.22 | -0.29 | -0.36 | -0.29 | Upgrade
|
| Gross Margin | - | -274.53% | -210.98% | -90.75% | -185.66% | -136.05% | Upgrade
|
| Operating Margin | -480.04% | -379.90% | -289.04% | -137.45% | -254.20% | -191.00% | Upgrade
|
| Profit Margin | -352.80% | -282.63% | -317.13% | -113.32% | -180.00% | -141.43% | Upgrade
|
| Free Cash Flow Margin | -597.67% | -472.63% | -210.75% | -154.19% | -308.71% | -181.27% | Upgrade
|
| EBITDA | -30.04 | -28.44 | -28.21 | -21.24 | -22.64 | -23.73 | Upgrade
|
| EBITDA Margin | - | - | -272.74% | -123.22% | -236.48% | -178.45% | Upgrade
|
| D&A For EBITDA | 1.13 | 1.57 | 1.69 | 2.45 | 1.7 | 1.67 | Upgrade
|
| EBIT | -31.17 | -30.01 | -29.9 | -23.7 | -24.34 | -25.4 | Upgrade
|
| EBIT Margin | - | - | -289.04% | -137.45% | -254.20% | -191.00% | Upgrade
|
| Revenue as Reported | 6.49 | 7.9 | 10.34 | 17.41 | 9.92 | 13.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.